Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Control Bionics Ltd. ( (AU:CBL) ) is now available.
Control Bionics Limited has applied to the ASX for quotation of 8,443,747 new fully paid ordinary shares under the code CBL, with an issue date of 31 December 2025. The move formalises the listing of these previously announced securities, expanding the company’s quoted share base and potentially increasing liquidity for existing investors while signalling ongoing capital markets activity as the business continues to execute its previously disclosed transactions.
The most recent analyst rating on (AU:CBL) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on Control Bionics Ltd. stock, see the AU:CBL Stock Forecast page.
More about Control Bionics Ltd.
Average Trading Volume: 1,133,131
Technical Sentiment Signal: Buy
Current Market Cap: A$25.83M
For a thorough assessment of CBL stock, go to TipRanks’ Stock Analysis page.